Your browser doesn't support javascript.
loading
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.
Li, Jie; Chin, Christopher R; Ying, Hsia-Yuan; Meydan, Cem; Teater, Matthew R; Xia, Min; Farinha, Pedro; Takata, Katsuyoshi; Chu, Chi-Shuen; Jiang, Yiyue; Eagles, Jenna; Passerini, Verena; Tang, Zhanyun; Rivas, Martin A; Weigert, Oliver; Pugh, Trevor J; Chadburn, Amy; Steidl, Christian; Scott, David W; Roeder, Robert G; Mason, Christopher E; Zappasodi, Roberta; Béguelin, Wendy; Melnick, Ari M.
  • Li J; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Chin CR; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Ying HY; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Meydan C; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Teater MR; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Xia M; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Farinha P; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Takata K; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Chu CS; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Jiang Y; BC Cancer Centre for Lymphoid Cancer, Department of Pathology and Laboratorial Medicine, University of British Columbia, Vancouver, Canada.
  • Eagles J; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, Canada.
  • Passerini V; The Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY, USA.
  • Tang Z; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Rivas MA; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Weigert O; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Pugh TJ; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Ludwig-Maximilians University (LMU) Hospital, Munich, Germany.
  • Chadburn A; The Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY, USA.
  • Steidl C; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Scott DW; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Ludwig-Maximilians University (LMU) Hospital, Munich, Germany.
  • Roeder RG; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Mason CE; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Zappasodi R; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Béguelin W; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Melnick AM; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, Canada.
Nat Commun ; 15(1): 2879, 2024 Apr 03.
Article en En | MEDLINE | ID: mdl-38570506
ABSTRACT
Despite regulating overlapping gene enhancers and pathways, CREBBP and KMT2D mutations recurrently co-occur in germinal center (GC) B cell-derived lymphomas, suggesting potential oncogenic cooperation. Herein, we report that combined haploinsufficiency of Crebbp and Kmt2d induces a more severe mouse lymphoma phenotype (vs either allele alone) and unexpectedly confers an immune evasive microenvironment manifesting as CD8+ T-cell exhaustion and reduced infiltration. This is linked to profound repression of immune synapse genes that mediate crosstalk with T-cells, resulting in aberrant GC B cell fate decisions. From the epigenetic perspective, we observe interaction and mutually dependent binding and function of CREBBP and KMT2D on chromatin. Their combined deficiency preferentially impairs activation of immune synapse-responsive super-enhancers, pointing to a particular dependency for both co-activators at these specialized regulatory elements. Together, our data provide an example where chromatin modifier mutations cooperatively shape and induce an immune-evasive microenvironment to facilitate lymphomagenesis.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article